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Background: Pulmonary embolism is a blood clot that occurs in the lungs, which decreases the 
oxygen levels in the body. Large or multiple pulmonary emboli can be fatal. This case involves a 
20 year old female soccer player (goalkeeper) who was diagnosed with a pulmonary embolism 
during the middle of the regular season. Upon initial assessment, the athlete presented with 
soreness and redness over her left distal adductors after getting cleated during practice a few 
days earlier. The initial assessment was adductor tendinitis and treated conservatively. 
Subsequently, the area became hot, red, and painful and the athlete was removed from practice. 
Eventually signs and symptoms resolved and the athlete returned to full participation. Several 
weeks later, the athlete presented with right sided chest pain and visited the campus health 
center. Differential diagnosis: Musculoskeletal pain, pericarditis, pleuritis. Treatment: The 
athlete was referred to the emergency room after blood work was performed. The athlete was 
told she could not exercise for at least three months. During this time, she was placed on 
anticoagulants. After the season ended, the athlete was told she could no longer play contact 
sports after a CT scan revealed pulmonary embolism. Uniqueness: Typically, patients with 
pulmonary embolism will present with chest pain, shortness of breath, and hypoxia. In addition, 
the incidence of pulmonary embolism is extremely rare in young, healthy athletes with no 
significant medical history.  Conclusion: Although most patients with pulmonary embolism have 
had surgery or are elderly and generally unhealthy, the majority tend to recover. These patients 
tend to have recurrent pulmonary emboli in the future after their primary embolism. In a young, 
healthy population, factors that increase the risk of developing pulmonary embolism are cancer, 
fractures of the hip or leg, oral contraceptives, major surgery, acute medical illness, obesity, or a 
sedentary lifestyle. It is critical that athletic trainers recognize early signs and symptoms of 
pulmonary embolism which warrants emergency management. Word Count: 316 
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Introduction: 
 Pulmonary embolism (PE) is a blood clot that blocks a lung artery creating damage to 
that part of the lung and can lead to hypertension.1 PE can also cause lower oxygen levels in the 
blood, damage other organs due to low blood supply, and even death. Pulmonary embolism is 
generally caused from a blood clot formed in the vein of a leg and travels to the lungs.1  
 Pulmonary embolisms can be categorized as either chronic or acute.2 An acute pulmonary 
embolism develops in a short period of time. They are either treated and dissolves away or result 
in mortality.2 A chronic PE occurs, when an acute PE is unable to completely dissolve.2 There 
are two subsets of acute PE that are categorized by the presence or absence of a major 
predisposing factor, embolus mobility, the size, and the pulmonary involvement. These subsets 
are submassive and massive.2 When the right ventricular dysfunctions without hemodynamic 
instability, which is identified through an electrocardiography. If several submassive pulmonary 
emboli go undiagnosed, they can lead to a massive pulmonary embolism. A massive PE occurs 
when blood pressure decreases more than 40 mm Hg for longer than 15 minutes, systolic blood 
pressure less than 90 mm Hg, and pulmonary vasculature obstruction of more than 50 percent.2 
Knowing what kind of pulmonary embolism the individual had can help health care 
professionals monitor vital signs and symptoms and reduce the risk of the individual getting 
more PE in the future.  
PE is commonly found in individuals who have had surgery, are generally unhealthy, or 
are elderly.1 The majority of these patients tend to recover. In 25% of people with PE, their first 
symptom is sudden death.3,4 Approximately one third of the patients that do recover tend to have 
recurrent pulmonary emboli within ten years after their primary embolism.3 In a young, healthy 
population, factors that increase the risk of developing pulmonary embolism are cancer, fractures 
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of the hip or leg, oral contraceptives, major surgery, acute medical illness, obesity, or a sedentary 
lifestyle. There have only been a few documented cases of competitive athletes sustaining a 
pulmonary embolism.5 The occurrence of PE is often times due to the clotting protein mutation 
some individuals have.   
 Factor V is a clotting protein found in the body.6 There are many anti-clotting proteins 
that help to break the factor V, to help it from forming clots where they are not needed. Factor V 
Leiden is a mutation that is a risk factor for venous thromboembolism, because it makes it harder 
for the anticlotting proteins to break up the factor V.6 Most people with the mutation never 
develop abnormal blood clots. However, some develop blood clots that can lead to long-term 
health problems or become life-threatening. Although both men and women can have factor V 
Leiden, women have an increased tendency to develop blood clots while pregnant or taking 
hormone estrogen. The majority of people who have factor V Leiden never know because they 
never exhibit any signs or symptoms.6 A blood clot may be the first indication of factor V 
Leiden.6 Anticoagulants are a common medication for individuals who have factor V Leiden and 
have developed blood clots.   
CASE REPORT  
 A 19-year-old female National Collegiate Athletic Association Division I soccer player 
(goalie) presented in the athletic training clinic, during pre-season with soreness and redness over 
her left distal adductors reporting that she had been cleated during a camp she had coached at. 
The athlete had equal strength, but side to side movement was painful. She was tender to palpate 
over her distal adductors. Medical history revealed that the athlete was taking oral contraceptive 
pills daily, had no recent travel, no recent long car trips, was not a smoker, and had no family 
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history of cardiac conditions or blood clots. The initial assessment was adductor tendinitis and 
she was treated conservatively. Over the next few days, many therapies were attempted: 
corrective exercises, Graston technique, massage, dry needling, and myofascial release. 
Myofascial release was the only therapy that provided any relief of the pain, besides rest. 
Subsequently, the area became hot and red for a few days. During this time, the athlete was still 
removed from participation and was icing the area that was hot and red area. Eventually signs 
and symptoms resolved and the athlete returned to full participation. The athlete mentioned later 
that she had felt intense pain with certain movements during practices that would bother her. She 
always felt that she could work through this pain.  
A few weeks later, the athlete went in one morning to the health center on campus. She 
was having right sided chest pain and was in obvious discomfort. The day before the athlete 
reported having the same pain that started in her upper right chest, worked its way into the lower 
right chest along her ribs.  The athlete took 800 mg of ibuprofen the night before with no relief.  
The exam reported the athlete’s vital signs were all within normal limits, her lungs were clear to 
auscultation with good air movement, there were no rales or wheezing. The athlete was non-
tender to palpate along lower right ribcage, no pain reproduced with palpation, her abdomen was 
soft, not distended, and her upper right quadrant was non-tender to palpate.  
The physician at the campus health center gave a 60 mg IM injection of toradol which 
offered no relief to the athlete. A chest x-ray showed early signs of pneumonia. A D-dimer was 
ordered as well, because the symptoms were not equivalent with pneumonia symptoms. A D-
dimer or Fibrin Degradation Fragment is a lab test that assists in ruling out deep vein thrombosis, 
pulmonary embolism, and stroke.7 It may be ordered when the patient presents with sudden 
shortness of breath, labored breathing, coughing, lung-related chest pain, and/or a rapid heart 
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rate.7 A positive D-dimer test indicates abnormally high levels of fibrin degradation products in 
the blood.7 The findings were inconclusive that it was truly a pulmonary embolism and the 
athlete was referred to the emergency department for an evaluation at a hospital in town.  
In the emergency department, the athlete was diagnosed with acute pulmonary embolism 
on the right side.  She was given oxycodone-acetaminophen for pain and XAREL(rivaroxaban) 
twice daily for 21 days. The athlete was instructed to return to the emergency room if she 
produced a fever, cough, bloody cough, worsening chest pain, or difficulty breathing. The athlete 
was informed to remain on anticoagulants for three months and removed from practices.  
After three months, the athlete went back to the hospital for a CT Chest Angiography. 
The CT showed resolution to the pulmonary thromboembolic disease and no evidence of any 
new pulmonary emboli.  The athlete was informed that she could return to full participation 
which included running, lifting, and soccer practices. A month later at a follow up appointment 
at the hospital, the athlete had additional blood work performed which determined that she had a 
factor V Leiden mutation on both alleles. The factor V Leiden mutation is a risk factor for 
venous thromboembolism. Because factor V Leiden mutation increasing her chance of a blood 
contact after possibly getting hit, the athlete was forced to end her soccer career early. However, 
the athlete is still leads an active lifestyle with basic running and weightlifting.  
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Introduction: 
 Pulmonary embolism (PE) is a blood clot that blocks a lung artery creating damage to the 
lung and can lead to hypertension.1 PE can also cause lower oxygen levels in the blood, damage 
other organs due to low blood supply, and death. Pulmonary embolism is generally caused from 
a blood clot formed in the vein of a leg and travels to the lungs.1  
 Pulmonary embolisms can be categorized as either chronic or acute.2 An acute pulmonary 
embolism develops in a short period of time. They are either treated and dissolve away, or result 
in mortality.2 A chronic PE occurs when an acute PE is unable to completely dissolve.2 There are 
two subsets of acute PE that are categorized by the presence or absence of a major predisposing 
factor, embolus mobility, size, and pulmonary involvement. These subsets are submassive and 
massive.2 A submassive pulmonary embolism occurs acutely without system hypotension 
(systolic blood pressure greater than 90 mm Hg), but with either myocardial necrosis 
(disorganized breakdown of heart tissue) or right ventricular (RV) dysfunction without a change 
in hemodynamic instability (abnormal or unstable blood pressure).2,3 This can only be identified 
through electrocardiography.2 Myocardial necrosis occurs if the elevation of troponin I is greater 
than 0.4 ng/mL or the elevation of troponin T is greater than 0.1 ng/mL.3 Troponin I and T are 
specific and sensitive indicators of damage to the myocardium.4  Right ventricular dysfunction 
presents in one of the following ways: right ventricle systolic dysfunction on echocardiography, 
right ventricle dilation on a computerized tomography (CT scan), elevation of B-type natriuretic 
peptide (BNP) greater than 90 pg/mL, elevation of N-terminal pro-BNP (greater than 500 
pg/mL), or electrocardiographic changes (new complete or incomplete right bundle-branch 
block, anteroseptal ST elevation or depression, or anteroseptal T-wave inversion).3 All are 
markers that are proven to be useful in diagnosing cardiovascular disorders.  
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If several submassive pulmonary emboli go undiagnosed, they can lead to a massive 
pulmonary embolism. A massive PE occurs when blood pressure decreases more than 40 mm Hg 
for longer than 15 minutes, systolic blood pressure less than 90 mm Hg, pulmonary vasculature 
obstruction of more than 50 percent, or requires inotropic support (medicines that change the 
force of the heart's contractions) not due to a cause other than a pulmonary embolism 
(arrhythmia, hypovolemia, sepsis, left ventricular dysfunction, pulselessness, or persistent 
profound bradycardia (heart rate less than 40 bpm with signs of shock).2,3 Knowing the type of 
pulmonary embolism, the individual can help health care professionals monitor vital signs and 
symptoms and reduce the risk of recurring PE.  
Pulmonary embolism is commonly found in individuals who have had surgery, are 
generally unhealthy, or are elderly.1 The majority of these patients tend to recover. In 25% of 
people with PE, their first symptom is sudden death.5,6 Approximately one third of the patients 
that do recover tend to have recurrent pulmonary emboli within ten years after their primary 
embolism.5 In a young, healthy population, factors that increase the risk of developing 
pulmonary embolism are cancer, fractures of the hip or leg, oral contraceptives, major surgery, 
acute medical illness, obesity, or a sedentary lifestyle. There has only been one documented case 
of a collegiate athlete sustaining a pulmonary embolism.7 The occurrence of PE is often times 
due to the clotting protein mutation some individuals possess. 
Factor V is a clotting protein found in the body.8 There are many anti-clotting proteins 
that help to break the factor V, to help it from forming clots where they are not needed. Factor V 
Leiden is a mutation that is a risk factor for venous thromboembolism because it makes it harder 
for the anticlotting proteins to break up the factor V.8 Most people with the mutation never 
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develop abnormal blood clots. However, some develop blood clots that can lead to long-term 
health problems or become life-threatening. Although both men and women can have factor V 
Leiden, women have an increased tendency to develop blood clots while pregnant or taking the 
hormone estrogen. Factor V Leiden allele is present in about five percent of Caucasian 
individuals, nearly absent in Africans, Asians, and races with Asian ancestry such as 
Amerindians, Eskimos, and Polynesians.9 It is present in eighteen percent of Caucasian patients 
with venous thrombosis. Conversely, factor V Leiden is usually not found in non-Caucasian 
thrombotic patients.9 The majority of people who have this mutation never know because they 
never exhibit any signs or symptoms.8 A blood clot may be the first indication of factor V 
Leiden.8 Anticoagulants are a common medication for individuals who have factor V Leiden 
mutation and have developed blood clots.    
Case Report: 
 A 19-year-old female National Collegiate Athletic Association Division I soccer player 
(goalie) presented in the athletic training clinic with soreness and redness over her left distal 
adductors being cleated during a camp. The athlete had equal strength, but side to side movement 
was painful. She was tender to palpate over her distal adductors. Medical history revealed that 
the athlete was taking oral contraceptive pill Larin Fe daily, had no recent travel, no recent long 
car trips, was not a smoker, and had no family history of cardiac conditions or blood clots. The 
initial assessment was adductor tendinitis. She was treated conservatively. Over the next few 
days, many therapies were attempted: corrective exercises, Graston technique, massage, dry 
needling, and myofascial release. Myofascial release was the only therapy that provided any 
relief of the pain, besides rest. Subsequently, the area became hot and red for a few days. During 
this time, the athlete was still removed from participation and was icing the hot and red area. 
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Eventually, signs and symptoms resolved and the athlete returned to full participation. The 
athlete mentioned later she had felt a bothersome, intense pain with certain movements during 
practices. She always felt she could work through this pain.  
 A few weeks later, the athlete went to the health center on campus. She was having right 
sided chest pain and was in obvious discomfort. The athlete reported having the same pain the 
day before in her upper right chest, but it worked its way into the lower right chest along her ribs.  
The athlete took 800 mg of ibuprofen the night before with no relief.  The exam reported the 
athlete’s vital signs were all within normal limits, her lungs were clear to auscultation with good 
air movement, and there were no rales or wheezing. The athlete was non-tender to palpate along 
lower right ribcage, no pain reproduced with palpation, her abdomen was soft, not distended, and 
her upper right quadrant was non-tender to palpate.  
The physician at the campus health center gave a 60 mg 
IM injection of toradol which offered no relief to the athlete. A 
chest x-ray showed early signs of pneumonia, shown in Figure 
1. A D-dimer was ordered as well because the symptoms were 
not equivalent with pneumonia symptoms. A D-dimer or Fibrin 
Degradation Fragment is a lab test that assists in ruling out deep 
vein thrombosis, pulmonary embolism, and stroke.10 It may be 
ordered when the patient presents with sudden shortness of 
breath, labored breathing, coughing, lung-related chest pain, 
and/or a rapid heart rate.10 A positive D-dimer test indicates abnormally high levels of fibrin 
degradation products in the blood.10 The findings were inconclusive for pulmonary embolism 
and the athlete was referred to the emergency department for an evaluation at a local hospital.  
Figure 1. Vague right lower lobe 
parenchymal opacity  
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In the emergency department, the athlete was diagnosed 
with acute pulmonary embolism on the right side.  She was given 
oxycodone-acetaminophen for pain and XAREL (rivaroxaban) 
twice daily for 21 days. The athlete was instructed to return to the 
emergency room if she produced a fever, cough, bloody cough, 
worsening chest pain, or difficulty breathing. Figure 2 illustrates 
the computerized tomography (CT) scans that were performed that 
show pulmonary embolism in both the right and left lungs. 
Because of the PE, the athlete was informed to remain on 
anticoagulants for three months and was removed from practices.  
After three months, the athlete went back to the hospital for 
a CT Chest Angiography. The CT showed resolution to the 
pulmonary thromboembolic disease and no evidence of any new 
pulmonary emboli as shown in Figure 3.  The athlete was informed 
she could return to full participation which included running, 
lifting, and soccer practices. A month later, at a follow up hospital 
appointment, the athlete had additional blood work performed 
which determined she had a factor V Leiden mutation on both 
alleles. The factor V Leiden mutation is a risk factor for venous thromboembolism. Because 
factor V Leiden mutation increases her chance of a blood clot after possibly getting hit, the 
athlete was forced to end her soccer career early.  
Figure 2. Top- Emboli in the 
left lower lobe and a filling 
defect in the central right 
lower lobe pulmonary artery 
extending into all of the 
subsegmental. Bottom- 
Peripheral infiltrate in the left 
posterior basilar right lower 
lobe 
 
Figure 3. Mild residual 
parenchymal opacity 
peripherally in the right lung 
base and interval resolution 
bilateral pulmonary 
thromembolitic disease 
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To this day, the athlete still leads an active lifestyle with basic running and weightlifting. 
The athlete has learned to be cautious and aware of how she is feeling while working out. She 
stays active to promote good blood flow, but is unable to play any contact sports.  Future 
lifestyle considerations for this athlete now include taking precautions while traveling (baby 
aspirin and compression socks), avoiding prescriptions or medications that contain estrogen, and 
obtaining regular blood work if placed on blood thinners again or wants to start having children.  
Discussion:  
 There are several documented cases of PE in young athletic populations. The first 
pulmonary embolism case report was in 1979 in a high school wrestler.11 The athlete reported flu 
like symptoms (fever, nausea, weakness, and myalgias) two days prior to a match.11 After the 
match, he was having trouble breathing for 30 minutes. Four days later, he competed again, this 
time being pinned; he became cyanotic and oxygen was administered.11 The next day his 
physician found a heart murmur after he complained of left scapular pain.11 The doctor also 
found that the gas pressure and pH in his heart were elevated enough that he needed heparin 
therapy. With no resolve, the athlete underwent median sternotomy bypass and total 
cardiopulmonary bypass.11 Emboli of unknown age were removed from both pulmonary arteries. 
The athlete was discharged from the hospital and received warafin sodium therapy.11 The athlete 
did fully recover, but it is not documented if he continued to play sports. In 2007, a high school 
male soccer player with no apparent risk factors had a sudden onset of dyspnea with no 
discernable cause.12 This athlete had an elevated D-dimer, but all lab results were within normal 
limits.12 The athlete had recurrent pulmonary emboli. The athlete was treated with the placement 
of a Greenfield inferior vena cava filter (prevent life-threatening pulmonary emboli). Two and a 
half years later, the athlete subsequently discontinued all anticoagulation therapy and remains 
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asymptomatic. It is not documented if the athlete continued to participate in contact sports. The 
last documented case of a pulmonary embolism in a high school athlete occurred in 2015.13 The 
athlete had exertional dyspnea for a year and a half. She was diagnosed with a massive PE.13 In 
2009, the first collegiate athlete with PE was documented.7 She was a gymnast with no previous 
history or family history of pulmonary or cardiac conditions and she presented with upper right 
and left quadrant pain.7 Her symptoms became so bad that, in less than five minutes, she would 
experience presyncope. Presyncope is a state consisting of lightheadedness, muscular weakness, 
blurred vision, and feeling faint. Because of these feelings she decided to go to a clinic. After 
further evaluation, she was referred to the team physician who referred her to the emergency 
room.7 She had an elevated D-dimer and all other blood tests were within normal limits. After a 
course of blood thinners, the athlete was allowed to return to full participation.  
Young, healthy athletes often times will not present with the classic symptoms associated 
with PE. Early diagnosis of pulmonary emboli is critical, but vague symptoms make it difficult 
to recognize. A differential diagnosis such as musculoskeletal pain, pleuritic, pericarditis, 
hyperventilation, and lung trauma should be considered when a patient presenting with 
abdominal pain, fever, productive cough, new onset of atrial fibrillation, hyperventilation, 
tachycardia, bradycardia, course breath sounds, dyspnea, or tachypnea (common symptoms 
found with pulmonary embolism).7,11,14 Athletes rarely sustain a PE, but delayed treatment could 
be fatal.  
Nonetheless, health care providers should understand and screen for inherited conditions, 
which, when coupled with oral contraceptive use, can create a high-risk scenario for pulmonary 
emboli. Screening for factor V Leiden mutation in individuals with no history of blood clots is 
currently recommended for individuals who are relatives of patients identified as carriers.9 There 
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is no data available to justify screening all athletes for the mutation; however, health care 
providers should take into consideration that oral contraceptives, pregnancy, or high-risk surgery 
increase the chance of pulmonary emboli.9 
Our soccer athlete may be the first athlete to sustain a career ending pulmonary 
embolism. Furthermore, she is the only case that presented with a positive factor V Leiden 
mutation and a non-elevated D-dimer. The athlete did not have any cardiac or pulmonary history, 
therefore there was no need for blood testing prior to this event. Therefore, as healthcare 
providers, we should be asking questions about family history or previous history of pulmonary 
embolism. Athletes who answer yes should receive further screening because they may have a 
higher likelihood of pulmonary embolism.   
Conclusion:  
 Pulmonary embolism is not commonly found in athletes; few cases have been reported. 
In this case, when the adductor injury became red and hot, referral was warranted. Although, 
common symptoms of deep vein thrombosis (DVT) are swelling, warm skin, red or discolored 
skin, or tired legs, DVTs are not commonly found in the adductors.15 Because the initial 
evaluation was diagnosed as adductor tendinitis, the possible deep vein thrombosis was missed. 
Making sure that health care professionals know the signs and symptoms of DVT and PE is 
important in making sure athletes are seeking proper medical treatment. If an athlete does 
complain of chest pain, difficulty breathing, or differences in normal heart beats, they should be 
referred to the team physician or emergency room. An early diagnosis of these symptoms is key 
for appropriate treatment and decreases the likelihood of mortality. Health care providers should 
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ensure proper screening and follow-up treatment, as well as monitor diagnosed athletes with PE 
to facilitate compliance.7 
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